Status:

UNKNOWN

The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis

Lead Sponsor:

Hacettepe University

Conditions:

Cystic Fibrosis

Postural Defect

Eligibility:

All Genders

18-45 years

Brief Summary

The study was conducted in the age range of 18-45 December, who were diagnosed with Cystic fibrosis.

Detailed Description

60 voluntary patients who have signed the consent form will be included. Within the scope of the research the demographic information of the individuals will be recorded. Functional capacities of indi...

Eligibility Criteria

Inclusion

  • Patients aged between 18-45 who were diagnosed with Cystic Fibrosis

Exclusion

  • In the last year, patients;
  • who had a fracture in any part of the patient's body
  • who had undergone spine surgery
  • who had an orthopedic, neurological or metastatic history in addition to Cystic Fibrosis

Key Trial Info

Start Date :

September 5 2023

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

February 16 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06088485

Start Date

September 5 2023

End Date

February 16 2024

Last Update

November 14 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hacettepe University, Health Sciences Faculty

Ankara, Turkey (Türkiye), 06100

The Effect of Bone Mineral Density in Patients With Adult Cystic Fibrosis | DecenTrialz